Johnson & Johnson Tops Profit Estimates but Trims Full-Year Outlook

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit

  • Order Reprints

  • Print Article

Johnson & Johnson

reported second-quarter adjusted earnings of $2.59 a share, topping analysts’ estimates, but the healthcare giant trimmed its fiscal-year adjusted earnings outlook.

Johnson & Johnson

(ticker: JNJ) shares were up 0.7% in premarket trading Tuesday to $175.42.